07:00 , Jun 19, 2014 |  BC Innovations  |  Distillery Therapeutics

Indication: Inflammation

Indication Target/marker/pathway Summary Licensing status Publication and contact information Inflammation Asthma Chemokine CC motif ligand 20 (CCL20; MIP3A) Mouse studies suggest the heparan sulfate-binding monosaccharide 2,4-O-disulfated iduronic...
07:00 , Aug 22, 2013 |  BC Innovations  |  Targets & Mechanisms

Tamping down TAU

Despite evidence that pathologic TAU spreads through the brain in tauopathies such as Alzheimer's disease and frontotemporal dementia, the actual mechanism by which the misfolded protein propagates is murky. A key player in the process...
08:00 , Jan 14, 2010 |  BC Innovations  |  Distillery Techniques

Technology: Disease models

Approach Summary Licensing status Publication and contact information Disease models Mouse model for multiple osteochondromatosis A mouse model could guide the development of therapies for multiple osteochondromatosis, an autosomal...
08:00 , Dec 17, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Multiple myeloma (MM) Exostosin glycosyltransferase 1 (EXT1); syndecan 1 (SDC1; CD138) A study in mice suggests that inhibiting...